The Role of Regorafenib in the Management of Advanced Gastrointestinal Stromal Tumors: A Systematic Review

Regorafenib, a multi-kinase inhibitor, has been widely used to treat patients with gastrointestinal stromal tumors (GIST) who failed the initial treatment with imatinib and sunitinib. This systematic review aims to demonstrate the efficacy and safety of regorafenib for patients with metastatic and/o...

Descripción completa

Detalles Bibliográficos
Autores principales: Khachatryan, Vahe, Muazzam, Asmaa, Hamal, Chandani, Velugoti, Lakshmi Sai Deepak Reddy, Tabowei, Godfrey, Gaddipati, Greeshma N, Mukhtar, Maria, Alzubaidee, Mohammed J, Dwarampudi, Raga Sruthi, Mathew, Sheena, Bichenapally, Sumahitha, Mohammed, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526434/
https://www.ncbi.nlm.nih.gov/pubmed/36199644
http://dx.doi.org/10.7759/cureus.28665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526434/
https://www.ncbi.nlm.nih.gov/pubmed/36199644
http://dx.doi.org/10.7759/cureus.28665

Ejemplares similares